What Does OncoResponse Do?

Total employees13
HeadquartersSeattle
Founded2016

OncoResponse is a clinical-stage immuno-oncology company at the forefront of cancer therapy development. By uniquely harnessing the power of the human immune system, OncoResponse identifies potent antibodies from "Elite Responders" – patients who have demonstrated exceptional and durable responses to cancer immunotherapies. This innovative approach allows the company to discover and develop novel therapeutics aimed at transforming cancer treatment paradigms and improving patient outcomes across various oncology indications. Their platform focuses on mining the human immune repertoire to unlock next-generation treatments.

Where Is OncoResponse's Headquarters?

HQ Function

Serves as the central hub for research and development, clinical program management, corporate operations, and strategic leadership.

Notable Features:

Located in a modern life sciences building in Seattle's Eastlake neighborhood, offering state-of-the-art laboratory and office facilities conducive to biotech innovation.

Work Culture:

A dynamic, collaborative, and science-driven environment focused on innovation in oncology. Employees are mission-oriented, dedicated to advancing cancer treatments for patients.

HQ Significance:

The Seattle location provides access to a rich biotech ecosystem, a highly skilled talent pool, and proximity to leading research institutions, crucial for OncoResponse's pioneering work.

Values Reflected in HQ: The headquarters reflects OncoResponse's commitment to cutting-edge science, innovation, and a focused approach to solving complex challenges in oncology.

Location:

While headquartered in Seattle, OncoResponse's operations have a global reach, particularly through its clinical trial activities which may be conducted in multiple countries. The company collaborates with international research institutions and partners to advance its pipeline of novel cancer therapeutics, aiming to address unmet medical needs for patients worldwide.

Street Address:

188 East Blaine Street, Suite 450

City:

Seattle

State/Province:

WA

Country:

USA

Where Else Does OncoResponse Operate Around the World?

No additional office locations available.

Buying Intent Signals for OncoResponse

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading OncoResponse? Meet the Executive Team

As of April 2025, OncoResponse' leadership includes:

Clifford J. Stocks - President & Chief Executive Officer
Anil K. Singhal, PhD - Chief Scientific Officer
Kamal D. Puri, PhD - Chief Business Officer
Robert M. Lechleider, MD - Chief Medical Officer
Chris Russell, CPA - Vice President, Finance and Corporate Controller
Joy R. Peter, JD - Vice President, Legal Affairs and Operations

Who's Investing in OncoResponse?

OncoResponse has been backed by several prominent investors over the years, including:

RiverVest Venture Partners
ARCH Venture Partners
Redmile Group
Canaan Partners
Helsinn Investment Fund
Qatar Investment Authority
Alexandria Venture Investments
BCM Ventures
Intermountain Ventures

What Leadership Changes Has OncoResponse Seen Recently?

Hire0
Exits0

OncoResponse has recently made key appointments to its Board of Directors to guide its strategic growth. No operational executive departures have been publicly announced in the last 12 months. A key Vice President role was filled approximately 13 months ago.

New Appointments:

Jon Wigginton, M.D., Jon Wigginton, M.D., appointed to OncoResponse's Board of Directors, bringing extensive oncology drug development experience.
Scott Megaffin, Scott Megaffin appointed to OncoResponse's Board of Directors, contributing significant industry leadership.
Chris Russell, CPA, Chris Russell, CPA, appointed as Vice President, Finance and Corporate Controller, strengthening financial leadership.

What Technology (Tech Stack) Is Used byOncoResponse?

Discover the tools OncoResponse uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

OncoResponse Email Formats and Examples

OncoResponse likely utilizes a common corporate email format. Based on patterns observed in similar biotech companies and general corporate practices, the most probable format is the first initial followed by the last name.

f[last]@oncoresponse.com

Format

jdoe@oncoresponse.com

Example

85%

Success rate

What's the Latest News About OncoResponse?

Business WireMay 16, 2024

OncoResponse Appoints Jon Wigginton, M.D., to its Board of Directors

OncoResponse announced the appointment of Jon Wigginton, M.D., to its Board of Directors. Dr. Wigginton brings extensive experience in oncology drug development and immuno-oncology to the company....more

Business WireApril 8, 2024

OncoResponse Presents Preclinical Data at the AACR Annual Meeting 2024 Supporting OR2805 as a Novel Therapeutic for Multiple Cancer Indications

OncoResponse shared promising preclinical data for its lead candidate OR2805 at the American Association for Cancer Research (AACR) Annual Meeting 2024. The data highlighted OR2805's potential in treating various cancers by targeting LILRB2, an immune checkpoint receptor....more

Business WireDecember 12, 2023

OncoResponse Doses First Patient in Phase 1/2 Clinical Trial of OR2805 in Patients with Advanced Cancer

OncoResponse announced that the first patient has been dosed in its Phase 1/2 clinical trial evaluating OR2805. OR2805 is a LILRB2 antagonist antibody being studied in patients with advanced solid tumors....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including OncoResponse, are just a search away.